Research and Markets: HIV - US Drug Forecast and Market Analysis to 2022

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/dthjt8/pharmapoint_hiv) has announced the addition of the "PharmaPoint: HIV - US Drug Forecast and Market Analysis to 2022" report to their offering.

Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS from a deadly disease to a manageable chronic condition for most infected individuals.

Antiretroviral treatment not only reduces the viral load and reconstitutes immune function, but also decreases infection incidence rates by limiting viral transmission. The treatment algorithm in HIV has characteristically involved multiple drug regimens designed to tackle the virus on different levels.

In the recent past, simplified dosing regimens through the emergence of single tablet regimens (STRs) or fixed dose combination (FDC) therapies have become increasingly popular amongst physicians and patients alike by increasing clinical efficacy thresholds and enabling patient compliance.

Atripla was the first STR to enter the US market in 2006, and since then, more companies have actively strategizing to develop STRs for this market. The main companies currently pursuing the development of STRs, and hence are well-positioned to be the future US market leaders, are ViiV Healthcare and Gilead Sciences.

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Catalyst

2.2 Related Reports

3 Disease Overview

3.1 Etiology and Pathophysiology

3.2 Symptoms

4 Disease Management

4.1 Treatment Overview

4.2 US

5 Competitive Assessment

5.1 Overview

5.2 Strategic Competitor Assessment

5.3 Product Profiles - Major Brands

6 Opportunity and Unmet Need

6.1 Overview

6.2 Unmet Needs Gap Analysis

6.3 Opportunities

7 Pipeline Assessment

7.1 Overview

7.2 Promising Drugs in Clinical Development

8 Market Outlook

8.1 United States

For more information visit http://www.researchandmarkets.com/research/dthjt8/pharmapoint_hiv

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals